102 results on '"Simopoulou, Mara"'
Search Results
2. Development of a predictive model for luteal phase oocyte retrieval in poor responders undergoing natural cycle IVF
- Author
-
Simopoulou, Mara, Galatis, Dionysios, Maziotis, Evangelos, Pantou, Agni, Giannelou, Polina, Grigoriadis, Sokratis, Tzonis, Panagiotis, Griva, Theodora, Zikopoulos, Athanasios, Philippou, Anastasios, Koutsilieris, Michael, Pantos, Konstantinos, and Sfakianoudis, Konstantinos
- Published
- 2022
- Full Text
- View/download PDF
3. Impact of Hysteroscopic Polypectomy on IVF Outcomes in Women with Unexplained Infertility.
- Author
-
Triantafyllidou, Olga, Korompokis, Ilias, Chasiakou, Stamatia, Bakas, Panagiotis, Kalampokas, Theodoros, Simopoulou, Mara, Tzanakaki, Despoina, Kalampokas, Emmanouil, Panagodimou, Evangelia, Xepapadaki, Maria, Christopoulos, Panagiotis, Valsamakis, Georgios, and Vlahos, Nikolaos F
- Subjects
HYSTEROSCOPIC surgery ,EMBRYO implantation ,HUMAN in vitro fertilization ,WOMEN'S hospitals ,POLYPECTOMY ,FERTILIZATION in vitro ,INDUCED ovulation - Abstract
Objective: To assess the effect of hysteroscopic polypectomy on the in vitro fertilization (IVF) results in infertile women with at least one prior negative IVF outcome. Methods: This retrospective cohort study included women who had attended the "2nd Department of Obstetrics and Gynecology of the National and Kapodistrian University of Athens" and "Iaso" Maternity Hospital from October 2019 to January 2023 for infertility treatment. The medical records of 345 women aged 18–45 years old without abnormal findings in hysterosalpingography (HSG) and with at least one previous failed IVF procedure were analyzed. The male factor was excluded, as well as a prior hysteroscopic removal of polyps. In 67 women, polyps were suspected during initial two-dimensional ultrasound (2D-US) examination. The final sample of the study comprised 40 patients, in which endometrial polyps were removed by hysteroscopy with the use of resectoscope. All patients underwent ovarian stimulation and IVF in the consecutive cycle using a short GnRh antagonist protocol. Main Results: After hysteroscopic polypectomy, 29 (72.5%) out of 40 patients had a positive pregnancy result: 26 (65%) clinical and 3 (7.5%) biochemical pregnancies were documented. There was a statistically significant difference between the number of clinical pregnancies before and after polypectomy (p < 0.001), as well as between the total number of pregnancies (p < 0.001). Secondary Results: Women with positive outcome were significantly younger and had significantly lower FSH levels (p < 0.007). They also had significantly higher AMH (p < 0.009) and peak estradiol levels (p < 0.013) and yielded more M II oocytes (p < 0.009) and embryos (p < 0.002). Conclusions: Hysteroscopic polypectomy in women with a suspected endometrial polyp using 2D ultrasound and a history of prior failed IVF attempt improves IVF outcomes in terms of the clinical and total number of pregnancies. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. The Role of One-Carbon Metabolism and Methyl Donors in Medically Assisted Reproduction: A Narrative Review of the Literature.
- Author
-
Sfakianoudis, Konstantinos, Zikopoulos, Athanasios, Grigoriadis, Sokratis, Seretis, Nikolaos, Maziotis, Evangelos, Anifandis, George, Xystra, Paraskevi, Kostoulas, Charilaos, Giougli, Urania, Pantos, Konstantinos, Simopoulou, Mara, and Georgiou, Ioannis
- Subjects
REPRODUCTIVE technology ,LITERATURE reviews ,FERTILIZATION in vitro ,METABOLISM ,VITAMIN B12 ,FOLIC acid ,ZINC supplements - Abstract
One-carbon (1-C) metabolic deficiency impairs homeostasis, driving disease development, including infertility. It is of importance to summarize the current evidence regarding the clinical utility of 1-C metabolism-related biomolecules and methyl donors, namely, folate, betaine, choline, vitamin B12, homocysteine (Hcy), and zinc, as potential biomarkers, dietary supplements, and culture media supplements in the context of medically assisted reproduction (MAR). A narrative review of the literature was conducted in the PubMed/Medline database. Diet, ageing, and the endocrine milieu of individuals affect both 1-C metabolism and fertility status. In vitro fertilization (IVF) techniques, and culture conditions in particular, have a direct impact on 1-C metabolic activity in gametes and embryos. Critical analysis indicated that zinc supplementation in cryopreservation media may be a promising approach to reducing oxidative damage, while female serum homocysteine levels may be employed as a possible biomarker for predicting IVF outcomes. Nonetheless, the level of evidence is low, and future studies are needed to verify these data. One-carbon metabolism-related processes, including redox defense and epigenetic regulation, may be compromised in IVF-derived embryos. The study of 1-C metabolism may lead the way towards improving MAR efficiency and safety and ensuring the lifelong health of MAR infants. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. The Effect of Open and Closed Oocyte Vitrification Systems on Embryo Development: A Systematic Review and Network Meta-Analysis.
- Author
-
Pantos, Konstantinos, Maziotis, Evangelos, Trypidi, Anna, Grigoriadis, Sokratis, Agapitou, Kristi, Pantou, Agni, Nikolettos, Konstantinos, Kokkini, Georgia, Sfakianoudis, Konstantinos, Pomeroy, Kimball O., and Simopoulou, Mara
- Subjects
VITRIFICATION ,OVUM ,FERTILITY preservation ,BLASTOCYST ,SURVIVAL rate - Abstract
Background/Objectives: Open and closed vitrification systems are commonly employed in oocyte cryopreservation; however, there is limited evidence regarding a comparison of their separate impact on oocyte competence. This study uniquely brings to the literature, data on the effect of open versus closed vitrification systems on laboratory and clinical outcomes, and the effect of cooling and warming rates. Methods: A systematic search of the literature was performed using the databases PubMed/MEDLINE and the Cochrane Central Library, limited to articles published in English up to January 2023. A network meta-analysis was conducted comparing each vitrification system versus fresh oocytes. Results: Twenty-three studies were included. When compared to fresh oocytes, both vitrification devices resulted in lower fertilization rates per MII oocyte retrieved. When comparing the two systems in terms of survival rates, no statistically significant difference was observed. However, interestingly open systems resulted in lower cleavage and blastocyst formation rates per 2 pronuclear (2PN) oocyte compared to fresh controls, while at the same time no statistically significant difference was detected when comparing closed devices with fresh oocytes. Conclusions: In conclusion, closed vitrification systems appear to exert a less detrimental impact on the oocytes' competence, which is reflected in the blastocyst formation rates. Proof of superiority of one system versus the other may lead to standardization, helping to ultimately determine optimal practice in oocyte vitrification. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
6. Navigating assisted reproduction treatment in the time of COVID-19: concerns and considerations
- Author
-
Simopoulou, Mara, Sfakianoudis, Konstantinos, Giannelou, Polina, Rapani, Anna, Siristatidis, Charalampos, Bakas, Panagiotis, Vlahos, Nikolaos, and Pantos, Konstantinos
- Published
- 2020
- Full Text
- View/download PDF
7. What is the true place of a double stimulation and double oocyte retrieval in the same cycle for patients diagnosed with poor ovarian reserve? A systematic review including a meta-analytical approach
- Author
-
Sfakianoudis, Konstantinos, Pantos, Konstantinos, Grigoriadis, Sokratis, Rapani, Anna, Maziotis, Evangelos, Tsioulou, Petroula, Giannelou, Polina, Kontogeorgi, Adamantia, Pantou, Agni, Vlahos, Nikolaos, Koutsilieris, Michael, and Simopoulou, Mara
- Published
- 2020
- Full Text
- View/download PDF
8. Embryo Transfer Procedural Parameters Do Not Predict IVF Cycle Outcome.
- Author
-
Sfakianoudis, Konstantinos, Maziotis, Evangelos, Trypidi, Anna, Grigoriadis, Sokratis, Vaxevanoglou, Terpsithea, Angeli, Irene, Rapani, Anna, Kotsifaki, Amalia, Pistola, Kalliopi, Pantou, Agni, Dafopoulos, Konstantinos, Pantos, Konstantinos, and Simopoulou, Mara
- Subjects
EMBRYO transfer ,FERTILIZATION in vitro ,CYCLING ,MATERNAL age ,STATISTICAL significance - Abstract
Background: this study aims to assess the effect of embryo transfer (ET) performance parameters of a technical nature on IVF outcome. Methods: A total of 1417 ETs from a single IVF center were included in this prospective observational study. The parameters investigated were as follows: the presence of cervical mucus post catheter withdrawal, the presence of blood, catheter reload, the employment of a tenaculum and stylet, catheter resistance as experienced by the physician and patient discomfort. Results: When ET performance parameters were associated with clinical outcomes on a singular level, none of the ET parameters presented with any statistical significance. The evaluation of covariates indicated that the number and the quality of transferred embryos, as well as maternal age, exerted a statistically significant effect on clinical outcomes. In a multivariate analysis, only the presence of mucus along with significant catheter resistance presented with statistical significance; however, when adjusting for covariates, this combination showed no statistically significant effect on clinical outcomes. Conclusions: the results indicate that the time-consuming process of recording and analyzing ET performance parameters fails to offer any additional value in predicting the cycle's outcome, while factors like embryo quality and number, as well as maternal age, seem to be the sole robust predictive factors of an IVF cycle. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. Treating infertility: current affairs of cross-border reproductive care
- Author
-
Simopoulou Mara, Sfakianoudis Konstantinos, Giannelou Polina, Pierouli Aikaterini, Rapani Anna, Maziotis Evangelos, Galatis Dionysios, Bakas Panagiotis, Vlahos Nikolaos, Pantos Konstantinos, and Koutsilieris Michael
- Subjects
cbrc ,risks ,bioethics ,art ,Medicine - Abstract
Infertility patients are willing to travel abroad to receive the medical treatment of choice. A 2010 study reported that approximately 25,000 couples travel abroad annually seeking infertility treatment. The purpose of this review is to analyze the criteria and risks related to cross-border reproductive care (CBRC) from the perspective of the patients and explore the issues raised regarding the country of origin and the destination country. A computerized search was performed in PubMed employing respective keywords. The total number of published articles provided by our PubMed search was 1905. Criteria for selecting the destination country include: the economic status, legislation, quality of care and anonymity. Despite the fact that CBRC is becoming a familiar concept, it raises concerns for the practitioner and issues of a social and bioethical nature. Most of them stem from the fact that health care acquires a commercialization aspect. Medical tourism entails several risks, such as misconceptions regarding the destination country, and legal issues arising from differences in the judiciary systems. Larger studies evaluating all aspects of CBRC are imperative. Quality assurance, a consensus and a common platform of practice, along with a system of international governance based on human rights, are a necessity for CBRC patients.
- Published
- 2019
- Full Text
- View/download PDF
10. Accuracy and efficacy of embryo transfer based on the previous measurement of cervical length and total uterine length
- Author
-
Bakas, Panagiotis, Simopoulou, Mara, Giner, Maria, Tzanakaki, Despina, and Deligeoroglou, Eythimios
- Published
- 2019
- Full Text
- View/download PDF
11. Evaluating the value of day 0 of an ICSI cycle on indicating laboratory outcome
- Author
-
Maziotis, E., Sfakianoudis, K., Giannelou, P., Grigoriadis, S., Rapani, A., Tsioulou, P., Nikolettos, K., Pantou, A., Tiptiri-Kourpeti, A., Koutsilieris, M., Asimakopoulos, B., Nikolettos, N., Pantos, K., and Simopoulou, Mara
- Published
- 2020
- Full Text
- View/download PDF
12. Couples with mild male factor infertility and at least 3 failed previous IVF attempts may benefit from laparoscopic investigation regarding assisted reproduction outcome
- Author
-
Pantou, Agni, Sfakianoudis, Konstantinos, Maziotis, Evangelos, Giannelou, Polina, Grigoriadis, Sokratis, Tsioulou, Petroula, Kokkali, Georgia, Koutsilieris, Michael, Pantos, Konstantinos, and Simopoulou, Mara
- Published
- 2020
- Full Text
- View/download PDF
13. Efficient treatment of chronic endometritis through a novel approach of intrauterine antibiotic infusion: a case series
- Author
-
Sfakianoudis, Konstantinos, Simopoulou, Mara, Nikas, Yorgos, Rapani, Anna, Nitsos, Nikolaos, Pierouli, Katerina, Pappas, Athanasios, Pantou, Agni, Markomichali, Christina, Koutsilieris, Michael, and Pantos, Konstantinos
- Published
- 2018
- Full Text
- View/download PDF
14. Commercially Available Molecular Approaches to Evaluate Endometrial Receptivity: A Systematic Review and Critical Analysis of the Literature.
- Author
-
Maziotis, Evangelos, Kalampokas, Theodoros, Giannelou, Polina, Grigoriadis, Sokratis, Rapani, Anna, Anifantakis, Marios, Kotsifaki, Amalia, Pantou, Agni, Triantafyllidou, Olga, Tzanakaki, Despoina, Neofytou, Spyridoula, Vogiatzi, Paraskevi, Bakas, Panagiotis, Simopoulou, Mara, and Vlahos, Nikolaos
- Subjects
FERTILIZATION in vitro ,EMBRYO transfer ,CRITICAL analysis ,EMBRYO implantation ,TECHNICAL information ,ENDOMETRIAL diseases - Abstract
Despite the advances in the field of reproductive medicine, implantation failure represents a challenging condition affecting 10–30% of patients subjected to in vitro fertilization (IVF). Research has focused on the identification of molecules playing crucial roles in endometrial receptivity, with the aim of designing predictive tools for efficient detection of the implantation window. To that end, novel molecular genomic and transcriptomic approaches have been introduced as promising tools to enable personalized approaches with the aim of optimizing embryo transfer dating. However, the clinical value of these approaches remains unclear. The aim of this study is to provide a systematic review and critical analysis of the existing evidence regarding the employment of commercially available novel approaches to evaluate endometrial receptivity. An Embase and PubMed/Medline search was performed on 1 February 2022. From the 475 articles yielded, only 27 were included and analyzed. The considerable heterogeneity of the included articles indicates the uniqueness of the implantation window, showcasing that the optimal time for embryo transfer varies significantly between women. Moreover, this study provides information regarding the technical aspects of these advanced molecular tools, as well as an analysis of novel possible biomarkers for endometrial receptivity, providing a basis for future research in the field. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
15. Sperm Morphology Assessment in the Era of Intracytoplasmic Sperm Injection: Reliable Results Require Focus on Standardization, Quality Control, and Training.
- Author
-
Agarwal, Ashok, Sharma, Rakesh, Gupta, Sajal, Finelli, Renata, Parekh, Neel, Panner Selvam, Manesh Kumar, Henkel, Ralf, Durairajanayagam, Damayanthi, Pompeu, Camila, Madani, Sarah, Belo, Andrea, Singh, Neha, Covarrubias, Simryn, Darbandi, Sara, Sadeghi, Raha, Darbandi, Mahsa, Vogiatzi, Paraskevi, Boitrelle, Florence, Simopoulou, Mara, and Saleh, Ramadan
- Subjects
SPERMATOZOA ,INTRACYTOPLASMIC sperm injection ,QUALITY control ,SEMEN analysis ,DIAGNOSTIC errors - Abstract
Semen analysis is the first, and frequently, the only step in the evaluation of male fertility. Although the laboratory procedures are conducted according to the World Health Organization (WHO) guidelines, semen analysis and especially sperm morphology assessment is very difficult to standardize and obtain reproducible results. This is mainly due to the highly subjective nature of their evaluation. ICSI is the choice of treatment when sperm morphology is severely abnormal (teratozoospermic). Hence, the standardization of laboratory protocols for sperm morphology evaluation represents a fundamental step to ensure reliable, accurate and consistent laboratory results that avoid misdiagnoses and inadequate treatment of the infertile patient. This article aims to promote standardized laboratory procedures for an accurate evaluation of sperm morphology, including the establishment of quality control and quality assurance policies. Additionally, the clinical importance of sperm morphology results in assisted reproductive outcomes is discussed, along with the clinical management of teratozoospermic patients. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
16. A Comprehensive Guide to Sperm Recovery in Infertile Men with Retrograde Ejaculation.
- Author
-
Gupta, Sajal, Sharma, Rakesh, Agarwal, Ashok, Parekh, Neel, Finelli, Renata, Shah, Rupin, Kandil, Hussein, Saleh, Ramadan, Arafa, Mohamed, Ko, Edmund, Simopoulou, Mara, Zini, Armand, Rajmil, Osvaldo, Kavoussi, Parviz, Singh, Keerti, Ambar, Rafael F., Elbardisi, Haitham, Sengupta, Pallav, Martinez, Marlon, and Boitrelle, Florence
- Subjects
NEURODEGENERATION ,MALE ejaculation ,MALE infertility ,ORAL medication ,SPERMATOZOA - Abstract
Retrograde ejaculation (RE) is a condition defined as the backward flow of the semen during ejaculation, and when present can result in male infertility. RE may be partial or complete, resulting in either low seminal volume or complete absence of the ejaculate (dry ejaculate). RE can result from anatomic, neurological or pharmacological conditions. The treatment approaches outlined are determined by the cause. Alkalinizing urinary pH with oral medications or by adding sperm wash media into the bladder prior to ejaculation may preserve the viability of the sperm. This article provides a step-by-step guide to diagnose RE and the optimal techniques to retrieve sperm. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
17. Relevance of Leukocytospermia and Semen Culture and Its True Place in Diagnosing and Treating Male Infertility .
- Author
-
Sharma, Rakesh, Gupta, Sajal, Agarwal, Ashok, Henkel, Ralf, Finelli, Renata, Parekh, Neel, Saleh, Ramadan, Arafa, Mohamed, Ko, Edmund, Zini, Armand, Tadros, Nicholas, Shah, Rupin, Ambar, Rafael F., Elbardisi, Haitham, Sengupta, Pallav, Martinez, Marlon, Boitrelle, Florence, Simopoulou, Mara, Vogiatzi, Paraskevi, and Gosalvez, Jaime
- Subjects
SEMEN analysis ,PEROXIDASE ,LEUCOCYTES ,OXIDATIVE stress - Abstract
The current WHO 2010 manual for human semen analysis defines leukocytospermia as the presence of peroxidase-positive leukocytes at a concentration >1×10[SUP 6] /mL of semen. Granular leukocytes when activated are capable of generating high levels of reactive oxygen species in semen resulting in oxidative stress. Oxidative stress has been correlated with poor sperm quality, increased level of sperm DNA fragmentation and low fertility potential. The presence of leukocytes and pathogens in the semen may be a sign of infection and/or localized inflammatory response in the male genital tract and the accessory glands. Common uro-pathogens including Chlamydia trachomatis, Ureaplasma urealyticum, Neisseria gonorrhoeae, Mycoplasma hominis, and Escherichia coli can cause epididymitis, epididymo-orchitis, or prostatitis. The relationship between leukocytospermia and infection is unclear. Therefore, we describe the pathogens responsible for male genital tract infections and their association with leukocytospermia. The review also examines the diagnostic tests available to identify seminal leukocytes. The role of leukocytospermia in male infertility and its management is also discussed. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
18. Reporting on the Value of Artificial Intelligence in Predicting the Optimal Embryo for Transfer: A Systematic Review including Data Synthesis.
- Author
-
Sfakianoudis, Konstantinos, Maziotis, Evangelos, Grigoriadis, Sokratis, Pantou, Agni, Kokkini, Georgia, Trypidi, Anna, Giannelou, Polina, Zikopoulos, Athanasios, Angeli, Irene, Vaxevanoglou, Terpsithea, Pantos, Konstantinos, and Simopoulou, Mara
- Subjects
EMBRYO transfer ,ARTIFICIAL intelligence ,FERTILIZATION in vitro ,RECEIVER operating characteristic curves ,PREDICTION models - Abstract
Artificial intelligence (AI) has been gaining support in the field of in vitro fertilization (IVF). Despite the promising existing data, AI cannot yet claim gold-standard status, which serves as the rationale for this study. This systematic review and data synthesis aims to evaluate and report on the predictive capabilities of AI-based prediction models regarding IVF outcome. The study has been registered in PROSPERO (CRD42021242097). Following a systematic search of the literature in Pubmed/Medline, Embase, and Cochrane Central Library, 18 studies were identified as eligible for inclusion. Regarding live-birth, the Area Under the Curve (AUC) of the Summary Receiver Operating Characteristics (SROC) was 0.905, while the partial AUC (pAUC) was 0.755. The Observed: Expected ratio was 1.12 (95%CI: 0.26–2.37; 95%PI: 0.02–6.54). Regarding clinical pregnancy with fetal heartbeat, the AUC of the SROC was 0.722, while the pAUC was 0.774. The O:E ratio was 0.77 (95%CI: 0.54–1.05; 95%PI: 0.21–1.62). According to this data synthesis, the majority of the AI-based prediction models are successful in accurately predicting the IVF outcome regarding live birth, clinical pregnancy, clinical pregnancy with fetal heartbeat, and ploidy status. This review attempted to compare between AI and human prediction capabilities, and although studies do not allow for a meta-analysis, this systematic review indicates that the AI-based prediction models perform rather similarly to the embryologists' evaluations. While AI models appear marginally more effective, they still have some way to go before they can claim to significantly surpass the clinical embryologists' predictive competence. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
19. Sperm DNA Fragmentation: A Critical Assessment of Clinical Practice Guidelines.
- Author
-
Agarwal, Ashok, Farkouh, Ala’a, Parekh, Neel, Zini, Armand, Arafa, Mohamed, Kandil, Hussein, Tadros, Nick, Busetto, Gian Maria, Ambar, Rafael, Parekattil, Sijo, Boitrelle, Florence, Sallam, Hassan, Jindal, Sunil, Ko, Edmund, Simopoulou, Mara, Hyun Jun Park, Sadighi, Mohammad Ali, Saleh, Ramadan, Ramsay, Jonathan, and Martinez, Marlon
- Subjects
SPERMATOZOA ,DNA ,MALE infertility ,OXIDATIVE stress ,MEN'S health - Abstract
Sperm DNA fragmentation (SDF) is implicated in male infertility and adverse reproductive outcomes. With the publication of many studies regarding the etiologies and contributors to SDF, as well as the effects of SDF, guidelines are necessary to aid clinicians in the application of SDF for male fertility evaluation. Two recent clinical practice guidelines were published by Agarwal et al and Esteves et al. In this article, we have evaluated and compared both guidelines. We have found fairly similar recommendations between the two guidelines and have also highlighted the differences between them. Finally, we have summarized and combined the best practice recommendations from both guidelines. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
20. International Fertility Education Initiative: research and action to improve fertility awareness.
- Author
-
Harper, Joyce C, Hammarberg, Karin, Simopoulou, Mara, Koert, Emily, Pedro, Juliana, Massin, Nathalie, Fincham, Anita, Balen, Adam, and Initiative, International Fertility Education
- Subjects
FERTILITY ,REPRODUCTIVE health ,AWARENESS ,PROFESSIONAL associations ,HEALTH education - Published
- 2021
- Full Text
- View/download PDF
21. Evaluating different strategies for poor ovarian response management: a retrospective cohort study and literature review.
- Author
-
Pantou, Agni, Giannelou, Polina, Grigoriadis, Sokratis, Maziotis, Evangelos, Tzonis, Panagiotis, Koutsouni, Anastasia, Pappa, Charikleia, Philippou, Anastassios, Koutsilieris, Michael, Pantos, Konstantinos, Simopoulou, Mara, and Sfakianoudis, Konstantinos
- Subjects
EMBRYO transfer ,LITERATURE reviews ,COHORT analysis ,OVUM ,RETROSPECTIVE studies ,EMBRYOS - Abstract
This retrospective study compares four different strategies for managing poor ovarian response (POR), namely, conventional stimulation (300 IUs) IVF–fresh embryo transfer (CONVF), mild stimulation (150 IUs) IVF–fresh embryo transfer (MILDF), mild stimulation embryo banking (MILDB), and embryo banking in natural cycles (NATB). In total, 796 POR patients were considered eligible. Statistical analysis revealed a shorter duration of stimulation and a lower required amount of gonadotropins in MILDF compared with CONVF (9.34 ± 1.17 versus 10.37 ± 1.14; 1402 ± 176 versus 3110 ± 343, P < 0.001). Comparing MILDF and MILDB, a higher number of available oocytes and embryos was observed in MILDB (2.36 ± 1.15 versus 6.58 ± 1.11; 1.72 ± 1.02 versus 3.51 ± 0.61, P < 0.001). Moreover, the MILDB presented with a lower number of required oocyte retrievals and a higher number of oocytes per oocyte retrieval compared with NATB (3.90 ± 1.56 versus 7.15 ± 1.80; 1.95 ± 0.74 versus 0.89 ± 0.20, P < 0.001). Data indicate that MILDF is equally efficient and associated with a shorter duration of stimulation and a lower required amount of gonadotropins compared with CONVF. Embryo accumulation may be more efficient compared with a fresh embryo transfer. MILDB may be a more efficient approach compared with NATB. To conclude, embryo accumulation following mild stimulation appears to form the optimal strategy for POR management. More studies are needed to verify these conclusions. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
22. Introducing intrauterine antibiotic infusion as a novel approach in effectively treating chronic endometritis and restoring reproductive dynamics: a randomized pilot study.
- Author
-
Pantos, Konstantinos, Simopoulou, Mara, Maziotis, Evangelos, Rapani, Anna, Grigoriadis, Sokratis, Tsioulou, Petroula, Giannelou, Polina, Nitsos, Nikolaos, Tzonis, Panagiotis, Koutsilieris, Michael, and Sfakianoudis, Konstantinos
- Subjects
- *
ENDOMETRITIS , *ANTIBIOTICS , *INFERTILITY , *ORAL medication , *HUMAN in vitro fertilization - Abstract
The chronic nature of Chronic Endometritis (CE) along with the challenging management and infertility entailed, call for cutting-edge therapeutic approaches. This study introduces the novel treatment of intrauterine antibiotic infusion (IAI) combined with oral antibiotic administration (OAA), and it assesses respective performance against the gold standard treatment of OAA. Data sourced herein reports on treatment efficiency and fertility restoration for both patients aiming to conceive naturally or via In Vitro fertilization. Eighty CE patients, 40 presenting with recurrent implantation failure, and 40 with recurrent pregnancy loss, were enrolled in the IVF and the natural conception arm respectively. Treatment was subjected to randomization. Effectively treated patients proceeded with either a single IVF cycle or were invited to conceive naturally over a 6-month period. Combination of IAI and OAA provided a statistically significant enhanced effectiveness treatment rate (RR 1.40; 95%CI 1.07–1.82; p = 0.01). No statistically significant difference was observed regarding the side-effects rate (RR 1.33; 95%CI 0.80–2.22; p = 0.52). No statistically significant difference was observed for either arm regarding live-birth rate. Following an intention-to-treat analysis, employment of IAI corresponds to improved clinical pregnancy rate-albeit not reaching statistical significance. In conclusion, complimentary implementation of IAI could provide a statistically significant enhanced clinical treatment outcome. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
23. PGT-A: who and when? Α systematic review and network meta-analysis of RCTs.
- Author
-
Simopoulou, Mara, Sfakianoudis, Konstantinos, Maziotis, Evangelos, Tsioulou, Petroula, Grigoriadis, Sokratis, Rapani, Anna, Giannelou, Polina, Asimakopoulou, Marilena, Kokkali, Georgia, Pantou, Amelia, Nikolettos, Konstantinos, Vlahos, Nikolaos, and Pantos, Konstantinos
- Subjects
- *
TREATMENT effectiveness , *GENETIC testing , *AGE groups , *YOUNG women , *ANEUPLOIDY , *EXTRATERRESTRIAL beings , *BIRTH rate , *META-analysis - Abstract
Purpose: Wide controversy is still ongoing regarding efficiency of preimplantation genetic testing for aneuploidy (PGT-A). This systematic review and meta-analysis, aims to identify the patient age group that benefits from PGT-A and the best day to biopsy. Methods: A systematic search of the literature was performed on MEDLINE/PubMed, Embase and Cochrane Central Library up to May 2020. Eleven randomized controlled trials employing PGT-A with comprehensive chromosomal screening (CCS) on Day-3 or Day-5 were eligible. Results: PGT-A did not improve live-birth rates (LBR) per patient in the general population (RR:1.11; 95%CI:0.87-1.42; n=1513; I2=75%). However, PGT-A lowered miscarriage rate in the general population (RR:0.45; 95%CI:0.25-0.80; n=912; I2=49%). Interestingly, the cumulative LBR per patient was improved by PGT-A (RR:1.36; 95%CI:1.13-1.64; n=580; I2=12%). When performing an age-subgroup analysis PGT-A improved LBR in women over the age of 35 (RR:1.29; 95%CI:1.05-1.60; n=692; I2=0%), whereas it appeared to be ineffective in younger women (RR:0.92; 95%CI:0.62-1.39; n=666; I2=75%). Regarding optimal timing, only day-5 biopsy practice presented with improved LBR per ET (RR: 1.37; 95% CI: 1.03-1.82; I2=72%). Conclusion: PGT-A did not improve clinical outcomes for the general population, however PGT-A improved live-birth rates strictly when performed on blastocyst stage embryos of women over the 35-year-old mark. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
24. SARS-CoV-2 vs. human gametes, embryos and cryopreservation.
- Author
-
Anifandis, George, Messini, Christina I., Simopoulou, Mara, Sveronis, George, Garas, Antonios, Daponte, Alexandros, and Messinis, Ioannis E.
- Subjects
H7N9 Influenza ,GAMETES ,COVID-19 ,SARS-CoV-2 ,COVID-19 pandemic ,HUMAN reproduction - Abstract
The COVID-19 pandemic, caused by the SARS-CoV-2 virus, is an unprecedented global situation, and all countries have adopted their own measurements to mitigate the spread of the virus in the first as well as in the subsequent waves of infection. All measures, especially in the first wave of the pandemic, were in combination with recommendations provided by professional and scientific organizations. Similar measures were applied to specific procedures, such as the management of infertility, including in vitro fertilization-embryo transfer (IVF-ET) treatments. Although there is no clear scientific evidence yet that the SARS-CoV-2 may exert negative effects on IVF outcome, especially at the early stages, several clinical reports indicate that the virus may impact male fertility through specific receptors presented at the somatic cells of the testis and used by the virus in order to gain entry to the respective cells. Nevertheless, it is not unreasonable to suspect that the virus may affect sperm function as well as oocyte performance directly through specific receptors or indirectly through other signaling pathways. Despite the good practice of IVF laboratory techniques, culture media may also be contaminated during equilibration when airborne virus's particles can contaminate culture media from an already infected embryology area or staff. Furthermore, although there is no clinical evidence, liquid nitrogen could be a route of infection for gametes and embryos when it has been contaminated during production or transportation. Therefore, cryopreservation of gametes and embryos must be virus-free. This communication aims to provide some aspects of the possible impact of the virus on gametes and embryos and how it may affect the cryopreservation procedures. Abbreviations: ACE2: angiotensin- converting enzyme 2; ART: assisted reproductive technology; ASRM: American Society for Reproductive Medicine; CDC: Centers for Disease Control and Prevention; COVID-19: coronavirus disease 2019; ESHRE: European Society of Human Reproduction and Embryology; ET: embryo transfer; FSH: follicle stimulating hormone; IFFS: International Federation of Fertility Societies; IVF: in vitro fertilization; LH: luteinizing hormone; LN: liquid nitrogen; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2; T: testosterone; WHO: World Health Organization. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
25. Investigating the Role of the microRNA-34/449 Family in Male Infertility: A Critical Analysis and Review of the Literature.
- Author
-
Pantos, Konstantinos, Grigoriadis, Sokratis, Tomara, Penelope, Louka, Ioanna, Maziotis, Evangelos, Pantou, Agni, Nitsos, Nikolaos, Vaxevanoglou, Terpsithea, Kokkali, Georgia, Agarwal, Ashok, Sfakianoudis, Konstantinos, and Simopoulou, Mara
- Subjects
MALE infertility ,CRITICAL analysis ,LITERATURE reviews ,HYDROSTATIC pressure - Abstract
There is a great body of evidence suggesting that in both humans and animal models the microRNA-34/449 (miR-34/449) family plays a crucial role for normal testicular functionality as well as for successful spermatogenesis, regulating spermatozoa maturation and functionality. This review and critical analysis aims to summarize the potential mechanisms via which miR-34/449 dysregulation could lead to male infertility. Existing data indicate that miR-34/449 family members regulate ciliogenesis in the efferent ductules epithelium. Upon miR-34/449 dysregulation, ciliogenesis in the efferent ductules is significantly impaired, leading to sperm aggregation and agglutination as well as to defective reabsorption of the seminiferous tubular fluids. These events in turn cause obstruction of the efferent ductules and thus accumulation of the tubular fluids resulting to high hydrostatic pressure into the testis. High hydrostatic pressure progressively leads to testicular dysfunction as well as to spermatogenic failure and finally to male infertility, which could range from severe oligoasthenozoospermia to azoospermia. In addition, miR-34/449 family members act as significant regulators of spermatogenesis with an essential role in controlling expression patterns of several spermatogenesis-related proteins. It is demonstrated that these microRNAs are meiotic specific microRNAs as their expression is relatively higher at the initiation of meiotic divisions during spermatogenesis. Moreover, data indicate that these molecules are essential for proper formation as well as for proper function of spermatozoa per se. MicroRNA-34/449 family seems to exert significant anti-oxidant and anti-apoptotic properties and thus contribute to testicular homeostatic regulation. Considering the clinical significance of these microRNAs, data indicate that the altered expression of the miR-34/449 family members is strongly associated with several aspects of male infertility. Most importantly, miR-34/449 levels in spermatozoa, in testicular tissues as well as in seminal plasma seem to be directly associated with severity of male infertility, indicating that these microRNAs could serve as potential sensitive biomarkers for an accurate individualized differential diagnosis, as well as for the assessment of the severity of male factor infertility. In conclusion, dysregulation of miR-34/449 family detrimentally affects male reproductive potential, impairing both testicular functionality as well as spermatogenesis. Future studies are needed to verify these conclusions. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
26. Abnormal fertilization in ICSI and its association with abnormal semen parameters: a retrospective observational study on 1855 cases.
- Author
-
Pantos, Konstantinos, Sfakianoudis, Konstantinos, Maziotis, Evangelos, Rapani, Anna, Karantzali, Eleni, Gounari-Papaioannou, Artemis, Vaxevanoglou, Terpsithea, Koutsilieris, Michael, and Simopoulou, Mara
- Abstract
Intracytoplasmic sperm injection (ICSI) efficiently addresses male factor infertility. However, the occurrence of abnormal fertilization, mainly characterized by abnormal pronuclei (PN) patterns, merits investigation. To investigate abnormal fertilization patterns following ICSI and identify their respective associations with abnormal parameters in semen analysis (SA), a retrospective observational study including 1855 cycles was performed. Male infertility diagnosis relied on the 2010 WHO criteria. The population was divided into groups based on their SA results. The presence of 2PNs and extrusion of the second polar body (PB) indicated normal fertilization. A Kruskal–Wallis test along with a Wilcoxon post hoc evaluation and Bonferroni correction was employed for comparison among the groups. For the pregnancy rate, logistic regression was employed. No correlation was established between the SA abnormalities and the 1PN or 3PN formation rates. The highest and lowest 0PN rates were reported for the oligoasthenoteratozoospermic and normal groups, respectively. The lowest cleavage formation rates were identified in the oligoasthenozoospermic and oligoasthenoteratozoospermic groups. The aforementioned groups along with the oligoteratozoospermic group similarly presented the lowest blastocyst formation rates. For the clinical pregnancy rate, no statistically significant difference was observed. In conclusion, the incidence of two or more abnormal SA parameters – with the common denominator being oligozoospermia – may jeopardize normal fertilization, cleavage, and blastocyst rates. Once the developmental milestone of achieving blastocyst stage status was achieved, only oligoasthenozoospermia and oligoasthenoteratozoospermia were associated with lower rates. Interestingly, following adjustment for the number of blastocysts, no statistically significant differences were observed. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
27. Effect of implant cleaning on titanium particle dissolution and cytocompatibility.
- Author
-
Kotsakis, Georgios A., Black, Rachel, Kum, Jason, Berbel, Larissa, Sadr, Ali, Karoussis, Ioannis, Simopoulou, Mara, and Daubert, Diane
- Abstract
Background: Peri-implantitis treatments are mainly based on protocols for teeth but have not shown favorable outcomes for implants. The potential role of titanium dissolution products in peri-implantitis necessitate the consideration of material properties in devising treatment protocols. We assessed implant cleaning interventions on (1) bacterial removal from Ti-bound biofilms, (2) Ti surface alterations and related Ti particle dissolution, and (3) cytocompatibility.Methods: Acid-etched Ti discs were inoculated with human peri-implant plaque biofilms and mechanical antimicrobial interventions were applied on the Ti-bound biofilms for 30 seconds each: (1) rotary nylon brush; (2) Ti brush; (3) water-jet on high and (4) low, and compared to sterile, untreated and Chlorhexidine-treated controls. We assessed colony forming units (CFU) counts, biofilm removal, surface changes via scanning electron microscopy (SEM) and atomic force microscopy (AFM), and Ti dissolution via light microscopy and Inductively-coupled Mass Spectrometry (ICP-MS). Biological effects of Ti particles and surfaces changes were assessed using NIH/3T3 fibroblasts and MG-63 osteoblastic cell lines, respectively.Results: Sequencing revealed that the human biofilm model supported a diverse biofilm including known peri-implant pathogens. WJ and Nylon brush were most effective in reducing CFU counts (P < 0.01 versus control), whereas Chlorhexidine was least effective; biofilm imaging results were confirmatory. Ti brushes led to visible streaks on the treated surfaces, reduced corrosion resistance and increased Ti dissolution over 30 days of material aging as compared to controls, which increase was amplified in the presence of bacteria (all P-val < 0.05). Ti particles exerted cytotoxic effects against fibroblasts, whereas surfaces altered by Ti brushes exhibited reduced osteoconductivity versus controls (P < 0.05).Conclusions: Present findings support that mechanical treatment strategies selected for implant biofilm removal may lead to Ti dissolution. Ti dissolution should become an important consideration in the clinical selection of peri-implantitis treatments and a necessary criterion for the regulatory approval of instruments for implant hygiene. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
28. Investigating apoptotic, inflammatory, and growth markers in poor responders undergoing natural in vitro fertilization cycles: a pilot study.
- Author
-
Sfakianoudis, Konstantinos, Tsioulou, Petroula, Maziotis, Evangelos, Grigoriadis, Sokratis, Glava, Argyro, Nitsos, Nikolaos, Giannelou, Polina, Makrakis, Evangelos, Pantou, Agni, Rapani, Anna, Koutsilieris, Michael, Mastorakos, George, Pantos, Konstantinos, and Simopoulou, Mara
- Subjects
FERTILIZATION in vitro ,GRANULOCYTES ,VASCULAR endothelial growth factors ,GRANULOCYTE-colony stimulating factor ,SOMATOMEDIN C - Abstract
This study investigates follicular fluid (FF) from patients with poor and normal ovarian response undergoing natural assisted reproductive technology cycles. We report about (1) cell‐free DNA (cfDNA), which reflects apoptosis; (2) corticotropin‐releasing hormone (CRH); (3) interleukin (IL)‐15, which reflects inflammation; (4) granulocyte colony–stimulating factor (G‐CSF); (5) vascular endothelial growth factor (VEGF); and (6) insulin‐like growth factor I (IGF‐I), which reflects follicular growth. Forty‐four poor responders and 44 normal responders—according to the Bologna criteria—were recruited. FF samples were prepared for cfDNA quantification employing Q‐PCR and for CRH, IL‐15, G‐CSF, VEGF, and IGF‐I quantification employing ELISA. Statistically nonsignificant different levels of FF cfDNA, CRH, IL‐15, VEGF, and IGF‐I were observed. Interestingly, statistically significant higher G‐CSF levels were observed in normal responders (302.48 ± 474.36 versus 200.10 ± 426.79 pg/mL, P = 0.003). Lower cfDNA integrity was observed in cycles resulting in clinical pregnancy for both groups (normal: 0.07 ± 0.04 versus 0.25 ± 0.17 ng/μL, P < 0.001; poor: 0.10 ± 0.06 versus 0.26 ± 0.12 ng/μL, P < 0.001). The results predominantly showcase similarities between normal and poor responders pertaining to inflammatory, apoptotic, and growth factors. This may be attributed to the employment of natural cycles in order to exclude controlled ovarian stimulation as a factor—indicating its detrimental effect. As G‐CSF levels presented significantly higher in normal responders, its vital role in understanding a compromised ovarian response is highlighted. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
29. COVID-19 and human reproduction: A pandemic that packs a serious punch.
- Author
-
Anifandis, George, Tempest, Helen G., Oliva, Rafael, Swanson, Grace M., Simopoulou, Mara, Easley, Charles A., Primig, Michael, Messini, Christina I., Turek, Paul J., Sutovsky, Peter, Ory, Steve J., and Krawetz, Stephen A.
- Subjects
HUMAN reproduction ,COVID-19 ,COVID-19 pandemic ,MIDDLE East respiratory syndrome ,INFLUENZA ,GRANZYMES ,ANGIOTENSIN I - Abstract
The COVID-19 pandemic has led to a worldwide health emergency that has impacted 188 countries at last count. The rapid community transmission and relatively high mortality rates with COVID-19 in modern times are relatively unique features of this flu pandemic and have resulted in an unparalleled global health crisis. SARS-CoV-2, being a respiratory virus, mainly affects the lungs, but is capable of infecting other vital organs, such as brain, heart and kidney. Emerging evidence suggests that the virus also targets male and female reproductive organs that express its main receptor ACE2, although it is as yet unclear if this has any implications for human fertility. Furthermore, professional bodies have recommended discontinuing fertility services during the pandemic such that reproductive services have also been affected. Although increased safety measures have helped to mitigate the propagation of COVID-19 in a number of countries, it seems that there is no predictable timeline to containment of the virus, a goal likely to remain elusive until an effective vaccine becomes available and widely distributed across the globe. In parallel, research on reproduction has been postponed for obvious reasons, while diagnostic tests that detect the virus or antibodies against it are of vital importance to support public health policies, such as social distancing and our obligation to wear masks in public spaces. This review aims to provide an overview of critical research and ethics issues that have been continuously emerging in the field of reproductive medicine as the COVID-19 pandemic tragically unfolds. Abbreviations: ACE2: angiotensin- converting enzyme 2; ART: Assisted reproductive technology; ASRM: American Society for Reproductive Medicine; CCR9: C-C Motif Chemokine Receptor 9; CDC: Centers for Disease Control and Prevention; COVID-19: Coronavirus disease 2019; Ct: Cycle threshold; CXCR6: C-X-C Motif Chemokine Receptor 6; ELISA: enzyme-linked immunosorbent assay; ESHRE: European Society of Human Reproduction and Embryology; ET: Embryo transfer; FSH: Follicle Stimulating Hormone; FFPE: formalin fixed paraffin embedded; FYCO1: FYVE And Coiled-Coil Domain Autophagy Adaptor 1; IFFS: International Federation of Fertility Societies; IUI: Intrauterine insemination; IVF: In vitro fertilization; LH: Luteinizing Hormone; LZTFL1: Leucine Zipper Transcription Factor Like 1; MAR: medically assisted reproduction services; MERS: Middle East Respiratory syndrome; NGS: Next Generation Sequencing; ORF: Open Reading Frame; PPE: personal protective equipment; RE: RNA Element; REDa: RNA Element Discovery algorithm; RT-PCR: Reverse=trascriptase transcriptase-polymerase chain reaction; SARS: Severe acute respiratory syndrome; SARS-CoV-2: Severe Acute Respiratory Syndrome Coronavirus 2; SLC6A20: Solute Carrier Family 6 Member 20; SMS: Single Molecule Sequencing; T: Testosterone; TMPRSS2: transmembrane serine protease 2; WHO: World Health Organization; XCR1: X-C Motif Chemokine Receptor [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
30. Novel Approaches in Addressing Ovarian Insufficiency in 2019: Are We There Yet?
- Author
-
Sfakianoudis, Konstantinos, Rapani, Anna, Grigoriadis, Sokratis, Retsina, Dimitra, Maziotis, Evangelos, Tsioulou, Petroula, Giannelou, Polina, Pantos, Konstantinos, Koutsilieris, Michael, Vlahos, Nikolaos, Mastorakos, George, and Simopoulou, Mara
- Subjects
PREMATURE ovarian failure ,MATERNAL age ,INDIVIDUALIZED medicine ,RANDOMIZED controlled trials ,PLATELET-rich plasma - Abstract
Ovarian insufficiency is described as a multifaceted issue typically encountered in the field of assisted reproduction. The three main identified diagnoses of ovarian insufficiency include premature ovarian failure (POF), poor ovarian response (POR), and advanced maternal age (AMA). Patient heterogeneity in the era of individualized medicine drives research forward leading to the emergence of novel approaches. This plethora of innovative treatments in the service of adequately managing ovarian insufficiency is called to undertake the challenge of addressing infertile patients exploring their reproductive options. This review provides an all-inclusive presentation and critical analysis on novel treatments that have not achieved routine clinical practice status yet, but have recently emerged as promising. In light of the lack of randomized controlled trials conveying safety and efficiency, clinicians are left puzzled in addressing the "how" and "for whom" these approaches may be beneficial. From ovarian injection employing platelet-rich plasma (PRP) or stem cells to artificial gametes and ovaries, ovarian transplantation, and mitochondrial replacement therapy, this descriptive review provides insight toward assisting the practitioner in decision making regarding these cutting-edge treatments. Biological mechanisms, invasiveness levels, efficiency, as well as possible complications, the current status along with bioethical concerns are discussed in the context of identifying future optimal treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
31. What will the future hold for artificial organs in the service of assisted reproduction: prospects and considerations.
- Author
-
Simopoulou, Mara, Sfakianoudis, Konstantinos, Tsioulou, Petroula, Rapani, Anna, Giannelou, Polina, Kiriakopoulos, Nikolaos, Pantou, Agni, Vlahos, Nikolaos, Anifandis, George, Bolaris, Stamatis, Pantos, Konstantinos, and Koutsilieris, Michael
- Abstract
Assisted reproduction provides a wide spectrum of treatments and strategies addressing infertility. However, distinct groups of infertile patients with unexplained infertility, congenital disorders, and other complex cases pose a challenge in in vitro fertilization (IVF) practices. This special cohort of patients is associated with futile attempts, IVF overuse, and dead ends in management. Cutting edge research on animal models introduced this concept, along with the development of artificial organs with the aim to mimic the respective physiological functions in reproduction. Extrapolation on clinical application leads to the future use of infertility management in humans. To date, the successful clinical application of artificial reproductive organs in humans is not feasible because further animal model studies are required prior to clinical trials. The application of these artificial organs could provide a solution to infertility cases with no other options. This manuscript presents an overview on the current status, future prospects, and considerations on the potential clinical application of artificial ovary, uterus, and gametes in humans. This paper presents how the IVF practice landscape may be shaped and challenged in the future, along with the subsequent concerns in assisted reproductive treatments. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
32. Artificial oocyte activation: physiological, pathophysiological and ethical aspects.
- Author
-
Anifandis, George, Michopoulos, Alexandros, Daponte, Alexandros, Chatzimeletiou, Katerina, Simopoulou, Mara, Messini, Christina I., Polyzos, Nikolas P., Vassiou, Katerina, Dafopoulos, Konstantinos, and Goulis, Dimitrios G.
- Subjects
INTRACYTOPLASMIC sperm injection ,EMBRYO transfer ,FERTILIZATION (Biology) ,CRYOPRESERVATION of organs, tissues, etc. ,BLASTOCYST - Abstract
Infertile couples with low oocyte yield in combination with abnormal semen parameters may experience intra-cytoplasmic sperm injection (ICSI) failure. An established factor associated with ICSI failure is oocyte activation deficiency (AOD). The latter originates from seminal contributors, such as phospholipase C-zeta (PLCζ) that is not adequate to produce calcium (Ca
2+ ) oscillations for oocyte activation. Apart from this natural activator, other stimulants, such as A23187, ionomycin, strontium chloride or even electric pulses, have been used in embryological laboratories to overcome AOD and ICSI failure. The aim of the present narrative review is to discuss the role of Ca+2 oscillations in oocyte activation and summarize the evidence concerning the use of oocyte activators as agents for artificial oocyte activation (AOA). Studies in humans and animals have emerged many physiological, pathophysiological and ethical aspects of AOA. In conclusion, in mammalian eggs, the cytosolic Ca+2 oscillations derive from a periodic release of Ca+2 from intracellular pools. PLCζ, as well as artificial stimulants, have been used to produce Ca+2 oscillations for AOA. As the latter may increase the risk of epigenetic induced malformations, further studies are required to clarify whether AOA constitutes an effective and safe method to overcome ICSI failure. Abbreviations: AOA: artificial oocyte activation; AOD: oocyte activation deficiency; Ca+2 : Calcium; CAMKII: Ca+2 /calmodulin-dependent protein kinase II; CICR: calcium-induced calcium-release; DAG: diacylglycerol; GM-CSF: granulocyte-macrophage colony-stimulating factor; ICSI: intra-cytoplasmic sperm injection; InsP3 R: inositol-trisphosphate receptor; IP3 : inositol 1,4,5-trisphosphate; IVF: in vitro fertilization; MAP: mitogen-activated protein; MII: metaphase II; NADP: nicotinic acid adenine dinucleotide phosphate; NO: nitric oxide; PAWP: post-acrosomal WW-binding domain protein; PIP2 : phosphatidylinositol 4,5-bisphosphate; PLC: phospholipase C; PLCζ: phospholipase C-zeta; SOAFs: spermatozoon-released oocyte-activating factors; Sr+2 : strontium; TFF: total fertilization failure [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
33. A Case Series on Platelet-Rich Plasma Revolutionary Management of Poor Responder Patients.
- Author
-
Sfakianoudis, Konstantinos, Simopoulou, Mara, Nitsos, Nikolaos, Rapani, Anna, Pantou, Agni, Vaxevanoglou, Terpsithea, Kokkali, Georgia, Koutsilieris, Michael, and Pantos, Konstantinos
- Subjects
- *
HUMAN in vitro fertilization , *PLATELET-rich plasma , *FOLLICLE-stimulating hormone , *CHILDBIRTH , *BIOMARKERS , *INFERTILITY treatment , *BIRTH rate , *FERTILIZATION in vitro , *SEX hormones , *INFERTILITY , *EVALUATION of medical care , *INDUCED ovulation , *OVUM , *PREGNANCY - Abstract
Poor responders are described as those In Vitro Fertilization (IVF) patients who are failing to respond to controlled ovarian stimulation protocols. Extensive research has focused on crafting the optimal treatment. However, it appears that each approach fails to be established as effective or guaranteed towards successful management. Platelet-Rich Plasma (PRP) is a novel, highly promising approach that has been successfully applied for an array of medical issues. In this case series, we present 3 poor responder patients with the common denominator of: failed IVF attempts, poor oocyte yield, and poor embryo quality. The option of oocyte donation was rejected. All patients were treated with autologous PRP ovarian infusion following written consent. Within a 3-month interval, follicle-stimulating hormone decreased by 67.33%, while Anti-Müllerian hormone increased by 75.18%. These impressive results on the biochemical infertility markers alone are classified as a complete biological paradox, coupled by improved embryo quality. Results report a natural conception at 24 weeks, an uncomplicated healthy pregnancy at 17 weeks and a successful live birth. To our knowledge, this is the first time such an approach and results are reported, where PRP treatment on poor responders lead to overcoming their challenging reproductive barrier. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
34. Making IVF more effective through the evolution of prediction models: is prognosis the missing piece of the puzzle?
- Author
-
Antoniou, Nikolaos, Maziotis, Evangelos, Rapani, Anna, Koutsilieris, Michael, Simopoulou, Mara, Bakas, Panagiotis, Kalampokas, Theodoros, Sfakianoudis, Konstantinos, Pantou, Agni, Pantos, Konstantinos, Anifandis, George, and Bolaris, Stamatis
- Subjects
FERTILIZATION in vitro ,EMBRYOLOGY ,BIOLOGICAL tags ,MITOCHONDRIAL DNA ,PREGNANCY - Abstract
Assisted reproductive technology has evolved tremendously since the emergence of in vitro fertilization (IVF). In the course of the recent decade, there have been significant efforts in order to minimize multiple gestations, while improving percentages of singleton pregnancies and offering individualized services in IVF, in line with the trend of personalized medicine. Patients as well as clinicians and the entire IVF team benefit majorly from ‘knowing what to expect’ from an IVF cycle. Hereby, the question that has emerged is to what extent prognosis could facilitate toward the achievement of the above goal. In the current review, we present prediction models based on patients’ characteristics and IVF data, as well as models based on embryo morphology and biomarkers during culture shaping a complication free and cost-effective personalized treatment. The starting point for the implementation of prediction models was initiated by the aspiration of moving toward optimal practice. Thus, prediction models could serve as useful tools that could safely set the expectations involved during this journey guiding and making IVF treatment more effective. The aim and scope of this review is to thoroughly present the evolution and contribution of prediction models toward an efficient IVF treatment. Abbreviations: IVF: In vitro fertilization; ART: assisted reproduction techniques; BMI: body mass index; OHSS: ovarian hyperstimulation syndrome; eSET: elective single embryo transfer; ESHRE: European Society of Human Reproduction and Embryology; mtDNA: mitochondrial DNA; nDNA: nuclear DNA; ICSI: intracytoplasmic sperm injection; MBR: multiple birth rates; LBR: live birth rates; SART: Society for Assisted Reproductive Technology Clinic Outcome Reporting System; AFC: antral follicle count; GnRH: gonadotrophin releasing hormone; FSH: follicle stimulating hormone; LH: luteinizing hormone; AMH: anti-Müllerian hormone; DHEA: dehydroepiandrosterone; PCOS: polycystic ovarian syndrome; NPCOS: non-polycystic ovarian syndrome; CE: cost-effectiveness; CC: clomiphene citrate; ORT: ovarian reserve test; EU: embryo-uterus; DET: double embryo transfer; CES: Cumulative Embryo Score; GES: Graduated Embryo Score; CSS: Combined Scoring System; MSEQ: Mean Score of Embryo Quality; IMC: integrated morphology cleavage; EFNB2: ephrin-B2; CAMK1D: calcium/calmodulin-dependent protein kinase 1D; GSTA4: glutathione S-transferase alpha 4; GSR: glutathione reductase; PGR: progesterone receptor; AMHR2: anti-Müllerian hormone receptor 2; LIF: leukemia inhibitory factor; sHLA-G: soluble human leukocyte antigen G. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
35. Osteostimulative calcium phosphosilicate biomaterials partially restore the cytocompatibility of decontaminated titanium surfaces in a peri‐implantitis model.
- Author
-
Karoussis, Ioannis. K., Kyriakidou, Kyriaki, Papaparaskevas, Joseph, Vrotsos, Ioannis A., Simopoulou, Mara, and Kotsakis, Georgios A.
- Abstract
Abstract: Bacterial peri‐implant biofilms, and the chemotherapeutics for their removal alter titanium surface cytocompatibility. In this study we aimed to assess the adjunctive use of an osteostimulative biomaterial utilizing a peri‐implantitis model under the hypothesis that it will increase cell migration towards treated titanium surfaces. Acid‐etched titanium surfaces were inoculated with a multi‐species biofilm model and treated with 1.5% NaOCl in a previously characterized in vitro peri‐implantitis model. Cell migration of MG63 cells towards the treated titanium surface (CTRL) was significantly reduced following inoculation with biofilm and chemotherapeutic treatment as compared to sterile controls. Addition of a tricalcium phosphate biomaterial (TCP) as a control for Ca
+2 had a small non‐significant effect, while BG significantly increased MG63 chemotaxis to titanium to levels comparable to sterile (STE). Similarly, cell viability at 5 days was increased in BG and TCP as compared to CTRL. SEM imaging confirmed the improved cytocompatibility of BG and TCP surfaces as compared to CTRL. Osteostimulative BG exhibited a strong chemotactic effect to osteoblasts, which was stronger than what was expected due to the chemotactic effect of Ca+2 alone (TCP). In addition, substantially increased cell attachment and viability was found on treated implant surfaces as compared to CTRL. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 106B: 2645–2652, 2018. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
36. Are computational applications the “crystal ball” in the IVF laboratory? The evolution from mathematics to artificial intelligence.
- Author
-
Simopoulou, Mara, Sfakianoudis, Konstantinos, Maziotis, Evangelos, Antoniou, Nikolaos, Rapani, Anna, Anifandis, George, Bakas, Panagiotis, Bolaris, Stamatis, Pantou, Agni, Pantos, Konstantinos, and Koutsilieris, Michael
- Subjects
- *
HUMAN in vitro fertilization , *PREGNANCY , *EMBRYOLOGISTS , *ARTIFICIAL intelligence , *COMPUTATIONAL biology - Abstract
Mathematics rules the world of science. Innovative technologies based on mathematics have paved the way for implementation of novel strategies in assisted reproduction. Ascertaining efficient embryo selection in order to secure optimal pregnancy rates remains the focus of the in vitro fertilization scientific community and the strongest driver behind innovative approaches. This scoping review aims to describe and analyze complex models based on mathematics for embryo selection, devices, and software most widely employed in the IVF laboratory and algorithms in the service of the cutting-edge technology of artificial intelligence. Despite their promising nature, the practicing embryologist is the one ultimately responsible for the success of the IVF laboratory and thus the one to approve embracing pioneering technologies in routine practice. Applied mathematics and computational biology have already provided significant insight into the selection of the most competent preimplantation embryo. This review describes the leap of evolution from basic mathematics to bioinformatics and investigates the possibility that computational applications may be the means to foretell a promising future for the IVF clinical practice. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
37. Association between male Infertility and seminal plasma levels of growth hormone and insulin‐like growth factor‐1.
- Author
-
Simopoulou, Mara, Philippou, Anastassios, Maziotis, Evangelos, Zevolis, Evangelos, Koutsilieris, Michael, Sfakianoudis, Konstantinos, Nitsos, Nikolaos, Pantos, Konstantinos, Bakas, Panagiotis, and Tenta, Roxane
- Subjects
- *
SOMATOMEDIN C , *SOMATOTROPIN , *ENZYME-linked immunosorbent assay , *SEMINAL proteins , *MALE infertility - Abstract
Abstract: Growth hormone (GH) and insulin‐like growth factor 1 (IGF‐1) have been proposed to play a pivotal role in male infertility due to their anabolic effects. The aim of this study was to investigate possible associations between seminal plasma levels of GH and IGF‐1 and sperm parameters. Fifty men participated in this study. Semen analysis was performed, while cell‐free seminal plasma was collected following sperm centrifugation. Seminal plasma concentrations of IGF‐1 and GH were determined by enzyme‐linked immunosorbent assay (ELISA). Due to the presence of asthenozoospermia in all participants who presented with abnormal sperm parameters, the participants were further subdivided into normal (group A), asthenozoospermic (group B) and asthenozoospermic plus at least one additional abnormal parameter (group C). A marginally nonsignificant statistical difference (p = 0.063) was revealed between the GH levels corresponding to the asthenozoospermic and the normal group with the latter presenting with higher GH levels. A statistically significant positive correlation (p < 0.05) was noted between levels of GH and IGF‐1 in group C. The above relationship has also been observed in men with low sperm concentration, vitality, volume and abnormal morphology. These novel findings require further investigation in order for the biological significance of those associations to be clarified. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
38. Improving ICSI: A review from the spermatozoon perspective.
- Author
-
Simopoulou, Mara, Gkoles, Laertis, Bakas, Panagiotis, Giannelou, Polina, Kalampokas, Theodoros, Pantos, Konstantinos, and Koutsilieris, Michael
- Subjects
- *
INTRACYTOPLASMIC sperm injection , *SPERMATOZOA , *HYALURONIC acid , *POLARIZATION microscopy , *CHROMATIN - Abstract
Intracytoplasmic sperm injection (ICSI) is the most frequently applied method for fertilization making the process of identifying the perfect spermatozoon fundamental. Herein we offer a critical and thorough presentation on the techniques reported regarding (i) handling and preparing semen samples, (ii) identifying and ‘fishing’ spermatozoa, and (iii) improving key factors, such as motility for a successful ICSI practice. These approaches are suggested to make the process easier and more effective especially in atypical and challenging circumstances. Furthermore, we present an epigrammatic opinion-where appropriate-based upon our collective experience. Techniques such as intracytoplasmic morphologically selected sperm injection, hyaluronic binding, polarized light microscopy, and annexin V agent identification for comparing sperm cells and their chromatin integrity are analyzed. Moreover, for the demanding cases of total sperm immotility the use of the hypoosmotic swelling test, methylxanthines, as well as the option of laser assisted immotile sperm selection are discussed. Finally, we refer to the employment of myoinositol as a way to bioreactively improve ICSI outcome for oligoasthenoteratozoospermic men. The diversity and the constant development of novel promising techniques to improve ICSI from the spermatozoon perspective, is certainly worth pursuing. The majority of the techniques discussed are still a long way from being established in routine practices of the standard IVF laboratory. In most cases an experienced embryologist could yield the same results. Although some of the techniques show great benefits, there is a need for large scale multicenter randomized control studies to be conducted in order to specify their importance before suggesting horizontal application. Taking into consideration thea prioriinvasive nature of ICSI, when clinical application becomes a possibility we need to proceed with caution and ensure that in the pursuit for innovation we are not sacrificing safety and the balance of the physiological and biological pathways of the spermatozoon’s dynamic. Abbreviations:ICSI: intracytoplasmic sperm injection; IVF:in vitrofertilization; PGD: reimplantation genetic diagnosis; IVM:in vitromaturation; HCV/HIV: hepatitis C virus/human immunodeficiency virus; IMSI: intracytoplasmic morphologically selected sperm injection; DGC: density gradient centrifugations; S-U: swim-up; ART: assisted reproduction technology; IUI: intrauterine insemination; PVP: polyvinylpyrrolidone; HA: hyaluronic acid; MSOME: motile sperm organelle morphology examination; ZP: zona pellucida; MACS: magnetic activation cell sorting; HOST: hypo-osmotic swelling test; TESE: testicular sperm extraction; MMP: mitochondrial membrane potential; OAT: oligoasthenoteratozoospermic [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
39. The Role of Interleukins in Recurrent Implantation Failure: A Comprehensive Review of the Literature.
- Author
-
Pantos, Konstantinos, Grigoriadis, Sokratis, Maziotis, Evangelos, Pistola, Kalliopi, Xystra, Paraskevi, Pantou, Agni, Kokkali, Georgia, Pappas, Athanasios, Lambropoulou, Maria, Sfakianoudis, Konstantinos, and Simopoulou, Mara
- Subjects
INTERLEUKINS ,LEUKEMIA inhibitory factor ,KILLER cells ,REGULATORY B cells ,REGULATORY T cells ,T cells ,TROPHOBLAST ,RECURRENT miscarriage - Abstract
Recurrent implantation failure (RIF) is a multifactorial condition affecting 10–15% of in vitro fertilization (IVF) couples. Data suggest that functional dysregulation of the endometrial immune system constitutes one of the main pathophysiological mechanisms leading to RIF. The aim of this article is to provide a thorough presentation and evaluation of the role of interleukins (ILs) in the pathogenesis of RIF. A comprehensive literature screening was performed summarizing current evidence. During implantation, several classes of ILs are secreted by epithelial and stromal endometrial cells, including IL-6, IL-10, IL-12, IL-15, IL-18, and the leukemia inhibitory factor. These ILs create a perplexing network that orchestrates both proliferation and maturation of uterine natural killer cells, controls the function of regulatory T and B cells inhibiting the secretion of antifetal antibodies, and supports trophoblast invasion and decidua formation. The existing data indicate associations between ILs and RIF. The extensive analysis performed herein concludes that the dysregulation of the ILs network indeed jeopardizes implantation leading to RIF. This review further proposes a mapping of future research on how to move forward from mere associations to robust molecular data that will allow an accurate profiling of ILs in turn enabling evidence-based consultancy and decision making when addressing RIF patients. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
40. Insights into the Role of Telomeres in Human Embryological Parameters. Opinions Regarding IVF.
- Author
-
Anifandis, George, Samara, Maria, Simopoulou, Mara, Messini, Christina I., Chatzimeletiou, Katerina, Thodou, Eleni, Daponte, Alexandros, and Georgiou, Ioannis
- Subjects
TELOMERES ,FERTILIZATION in vitro ,HUMAN in vitro fertilization ,REPRODUCTIVE technology ,MALE infertility ,FEMALE infertility ,CELLULAR aging - Abstract
Telomeres promote genome integrity by protecting chromosome ends from the activation of the DNA damage response and protecting chromosomes from the loss of coding sequences due to the end replication problem. Telomere length (TL) is progressively shortened as age progresses, thus resulting in cellular senescence. Therefore, TL is in strong adverse linear correlation with aging. Mounting evidence supports the notion that telomeres and male/female infertility are in a close relationship, posing the biology of telomeres as a hot topic in the era of human-assisted reproduction. Specifically, the length of sperm telomeres is gradually increasing as men get older, while the telomere length of the oocytes seems not to follow similar patterns with that of sperm. Nonetheless, the telomere length of the embryos during the cleavage stages seems to have a paternal origin, but the telomere length can be further extended by telomerase activity during the blastocyst stage. The latter has been proposed as a new molecular biomarker with strong predictive value regarding male infertility. As far as the role of telomeres in assisted reproduction, the data is limited but the length of telomeres in both gametes seems to be affected mainly by the cause of infertility rather than the assisted reproductive therapy (ART) procedure itself. The present review aims to shed more light into the role of telomeres in human embryological parameters, including gametes and embryos and also presents opinions regarding the association between telomeres and in vitro fertilization (IVF). [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
41. FISH analysis on day 5 post-insemination of human arrested and blastocyst stage embryos.
- Author
-
Ruangvutilert, Pornpimol, Delhanty, Joy D. A., Serhal, Paul, Simopoulou, Mara, Rodeck, Charles H., Harper, Joyce C., Ruangvutilert, P, Delhanty, J D, Serhal, P, Simopoulou, M, Rodeck, C H, and Harper, J C
- Published
- 2000
- Full Text
- View/download PDF
42. The Role of Uterine Natural Killer Cells on Recurrent Miscarriage and Recurrent Implantation Failure: From Pathophysiology to Treatment.
- Author
-
Sfakianoudis, Konstantinos, Rapani, Anna, Grigoriadis, Sokratis, Pantou, Agni, Maziotis, Evangelos, Kokkini, Georgia, Tsirligkani, Chrysanthi, Bolaris, Stamatis, Nikolettos, Konstantinos, Chronopoulou, Margarita, Pantos, Konstantinos, and Simopoulou, Mara
- Subjects
KILLER cells ,RECURRENT miscarriage ,PATHOLOGICAL physiology ,INTRAVENOUS therapy ,BIOMARKERS - Abstract
Uterine natural killer (uNK) cells constitute a unique uterine leucocyte subpopulation facilitating implantation and maintaining pregnancy. Herein, we critically analyze current evidence regarding the role of uNK cells in the events entailed in recurrent implantation failure (RIF) and recurrent miscarriages (RM). Data suggest an association between RIF and RM with abnormally elevated uNK cells' numbers, as well as with a defective biological activity leading to cytotoxicity. However, other studies do not concur on these associations. Robust data suggesting a definitive causative relationship between uNK cells and RIF and RM is missing. Considering the possibility of uNK cells involvement on RIF and RM pathophysiology, possible treatments including glucocorticoids, intralipids, and intravenous immunoglobulin administration have been proposed towards addressing uNK related RIF and RM. When considering clinical routine practice, this study indicated that solid evidence is required to report on efficiency and safety of these treatments as there are recommendations that clearly advise against their employment. In conclusion, defining a causative relationship between uNK and RIF–RM pathologies certainly merits investigation. Future studies should serve as a prerequisite prior to proposing the use of uNK as a biomarker or prior to targeting uNK cells for therapeutic purposes addressing RIF and RM. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
43. The Current Evidence Regarding COVID-19 and Pregnancy: Where Are We Now and Where Should We Head to Next?
- Author
-
Kalampokas, Theodoros, Rapani, Anna, Papageorgiou, Maria, Grigoriadis, Sokratis, Maziotis, Evangelos, Anifandis, George, Triantafyllidou, Olga, Tzanakaki, Despoina, Neofytou, Spyridoula, Bakas, Panagiotis, Simopoulou, Mara, and Vlahos, Nikolaos
- Subjects
COVID-19 ,PREGNANCY complications ,VIRAL transmission ,PREGNANCY ,SYMPTOMS ,BREASTFEEDING - Abstract
Despite the volume of publications dedicated to unraveling the biological characteristics and clinical manifestations of SARS-CoV-2, available data on pregnant patients are limited. In the current review of literature, we present an overview on the developmental course, complications, and adverse effects of COVID-19 on pregnancy. A comprehensive review of the literature was performed in PubMed/Medline, Embase, and Cochrane Central databases up to June 2021. This article collectively presents what has been so far reported on the identified critical aspects, namely complications during pregnancy, delivery challenges, neonatal health care, potential routes of viral transmission, including vertical transmission or breastfeeding, along with the risks involved in the vaccination strategy during pregnancy. Despite the fact that we are still largely navigating uncharted territory, the observed publication explosion in the field is unprecedented. The overwhelming need for data is undoubtable, and this serves as the driver for the plethora of publications witnessed. Nonetheless, the quality of data sourced is variable. In the midst of the frenzy for reporting on SARS-CoV-2 data, monitoring this informational overload is where we should head to next, considering that poor quality research may in fact hamper our attempts to prevail against this unparalleled pandemic outbreak. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
44. Empty Zona Pellucida Only Case: A Critical Review of the Literature.
- Author
-
Siristatidis, Charalampos, Tzanakaki, Despoina, Simopoulou, Mara, Vaitsopoulou, Christina, Tsioulou, Petroula, Stavros, Sofoklis, Papapanou, Michail, Drakakis, Peter, Bakas, Panagiotis, and Vlahos, Nikolaos
- Published
- 2021
- Full Text
- View/download PDF
45. Molecular Drivers of Developmental Arrest in the Human Preimplantation Embryo: A Systematic Review and Critical Analysis Leading to Mapping Future Research.
- Author
-
Sfakianoudis, Konstantinos, Maziotis, Evangelos, Karantzali, Eleni, Kokkini, Georgia, Grigoriadis, Sokratis, Pantou, Amelia, Giannelou, Polina, Petroutsou, Konstantina, Markomichali, Christina, Fakiridou, Maria, Koutsilieris, Michael, Asimakopoulos, Byron, Pantos, Konstantinos, and Simopoulou, Mara
- Subjects
HUMAN embryos ,CRITICAL analysis ,PARENT attitudes ,FERTILIZATION in vitro ,HUMAN in vitro fertilization ,MITOCHONDRIAL DNA - Abstract
Developmental arrest of the preimplantation embryo is a multifactorial condition, characterized by lack of cellular division for at least 24 hours, hindering the in vitro fertilization cycle outcome. This systematic review aims to present the molecular drivers of developmental arrest, focusing on embryonic and parental factors. A systematic search in PubMed/Medline, Embase and Cochrane-Central-Database was performed in January 2021. A total of 76 studies were included. The identified embryonic factors associated with arrest included gene variations, mitochondrial DNA copy number, methylation patterns, chromosomal abnormalities, metabolic profile and morphological features. Parental factors included, gene variation, protein expression levels and infertility etiology. A valuable conclusion emerging through critical analysis indicated that genetic origins of developmental arrest analyzed from the perspective of parental infertility etiology and the embryo itself, share common ground. This is a unique and long-overdue contribution to literature that for the first time presents an all-inclusive methodological report on the molecular drivers leading to preimplantation embryos' arrested development. The variety and heterogeneity of developmental arrest drivers, along with their inevitable intertwining relationships does not allow for prioritization on the factors playing a more definitive role in arrested development. This systematic review provides the basis for further research in the field. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
46. Getting to Know Endometriosis-Related Infertility Better: A Review on How Endometriosis Affects Oocyte Quality and Embryo Development.
- Author
-
Simopoulou, Mara, Rapani, Anna, Grigoriadis, Sokratis, Pantou, Agni, Tsioulou, Petroula, Maziotis, Evangelos, Tzanakaki, Despina, Triantafyllidou, Olga, Kalampokas, Theodoros, Siristatidis, Charalampos, Bakas, Panagiotis, Vlahos, Nikolaos, and Yoshino, Osamu
- Subjects
OVUM ,ENDOMETRIOSIS ,INFERTILITY ,EMBRYOS ,REACTIVE oxygen species ,GENE mapping - Abstract
Endometriosis-related infertility describes a case of deteriorated fecundity when endometriosis is diagnosed. Numerous mechanisms have been proposed in an effort to delineate the multifaceted pathophysiology that induces impairment of reproductive dynamics in patients with endometriosis. In this critical analysis, authors present the plethora of molecular events that are entailed and elaborate on how they potentially impair the oocyte's and embryo's competence in patients with endometriosis. Reactive oxygen species, dysregulation of the immune system and cellular architectural disruption constitute the crucial mechanisms that detrimentally affect oocyte and embryo developmental potential. The molecular level impairment of the reproductive tissue is discussed, since differentiation, proliferation and apoptosis constitute focal regulatory cellular functions that appear severely compromised in cases of endometriosis. Mapping the precise molecular mechanisms entailed in endometriosis-related infertility may help delineate the complex nature of the disorder and bring us a step closer to a more personalized approach in understanding, diagnosing and managing endometriosis-related infertility. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
47. The Conundrum of Poor Ovarian Response: From Diagnosis to Treatment.
- Author
-
Giannelou, Polina, Simopoulou, Mara, Grigoriadis, Sokratis, Makrakis, Evangelos, Kontogeorgi, Adamantia, Pantou, Agni, Galatis, Dionysios, Kalampokas, Theodoros, Bakas, Panagiotis, Bolaris, Stamatis, Pantos, Konstantinos, and Sfakianoudis, Konstantinos
- Subjects
- *
INDUCED ovulation , *STEM cell treatment , *OVARIAN function tests , *PLATELET-rich plasma , *REPRODUCTIVE technology , *BLOOD platelet disorders - Abstract
Despite recent striking advances in assisted reproductive technology (ART), poor ovarian response (POR) diagnosis and treatment is still considered challenging. Poor responders constitute a heterogeneous cohort with the common denominator of under-responding to controlled ovarian stimulation. Inevitably, respective success rates are significantly compromised. As POR pathophysiology entails the elusive factor of compromised ovarian function, both diagnosis and management fuel an ongoing heated debate depicted in the literature. From the criteria employed for diagnosis to the plethora of strategies and adjuvant therapies proposed, the conundrum of POR still puzzles the practitioner. What is more, novel treatment approaches from stem cell therapy and platelet-rich plasma intra-ovarian infusion to mitochondrial replacement therapy have emerged, albeit not claiming clinical routine status yet. The complex and time sensitive nature of this subgroup of infertile patients indicates the demand for a consensus on a horizontally accepted definition, diagnosis and subsequent effective treating strategy. This critical review analyzes the standing criteria employed in order to diagnose and aptly categorize POR patients, while it proceeds to critically evaluate current and novel strategies regarding their management. Discrepancies in diagnosis and respective implications are discussed, while the existing diversity in management options highlights the need for individualized management. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
48. Early Onset Preeclampsia Diagnosis Prior to the 20th Week of Gestation in a Twin Pregnancy Managed via Selective Reduction of an Intrauterine Growth Restriction Fetus: A Case Report and Literature Review.
- Author
-
Konstantopoulos, Anastasios, Sfakianoudis, Konstantinos, Simopoulou, Mara, Kontogeorgi, Adamantia, Rapani, Anna, Grigoriadis, Sokratis, Pantou, Agni, Bathrellos, Nikolaos, Grammatis, Alexandros, and Pantos, Konstantinos
- Subjects
FETAL development ,ABORTION ,PREECLAMPSIA ,PREGNANCY ,LITERATURE reviews - Abstract
A single, healthy, 44-year-old perimenopausal woman pursuing a pregnancy, employed donor embryos, resulting to a dichorionic diamniotic twin pregnancy. In the 18th week of gestation severe symptoms indicated early onset preeclampsia reporting severe hypertension (BP 180/90 mmHg), intense headaches and nausea as well as elevated 24-h urine protein levels (1.5 g/day). Concurrently diagnosis of an IUGR fetus was concluded. Standard pharmaceutical administration for treating preeclampsia was ordered. Persistence of symptoms indicated recommendation for pregnancy termination, however the patient opted against this. Selective embryo reduction was performed as the last resort prior to pregnancy termination. Following selective reduction the headaches and nausea were successfully subdued and the patient's blood pressure was adjusted (mean BP 130/80 mmHg). This enabled further progression of pregnancy for an impressive 11 week-period, and a live birth on the 30th week. To conclude, only a few rare cases have been reported with diagnosis of early onset preeclampsia prior to the 20th week mark and none report live births. Albeit termination of pregnancy was recommended, the management of selective reduction of the IUGR fetus enabled successful treatment of preeclampsia coupled by a live birth of a healthy infant without any perinatal or postnatal complications reported. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
49. Reactivating Ovarian Function through Autologous Platelet-Rich Plasma Intraovarian Infusion: Pilot Data on Premature Ovarian Insufficiency, Perimenopausal, Menopausal, and Poor Responder Women.
- Author
-
Sfakianoudis, Konstantinos, Simopoulou, Mara, Grigoriadis, Sokratis, Pantou, Agni, Tsioulou, Petroula, Maziotis, Evangelos, Rapani, Anna, Giannelou, Polina, Nitsos, Nikolaos, Kokkali, Georgia, Koutsilieris, Michael, and Pantos, Konstantinos
- Subjects
- *
PREMATURE ovarian failure , *PLATELET-rich plasma , *INTRACYTOPLASMIC sperm injection , *OVARIAN reserve - Abstract
Intraovarian platelet-rich plasma (PRP) infusion was recently introduced in the context of addressing ovarian insufficiency. Reporting on its effectiveness prior to adopting in clinical routine practice is imperative. This study aims to provide pilot data regarding PRP application for ovarian rejuvenation. Four pilot studies were conducted on poor ovarian response (POR), premature ovarian insufficiency (POI), perimenopause, and menopause, respectively. Each pilot study reports on thirty patients, 120 participants were recruited in total. All participants provided written informed consent prior to treatment. Primary outcome measures for the POR pilot study were levels of anti-müllerian hormone (AMH), antral follicle count (AFC) and oocyte yield. For the POI, perimenopausal and menopausal pilot studies primary outcome measures were restoration of menstrual cycle, and Follicle Stimulating Hormone (FSH) levels. A significant improvement on the hormonal profile and the ovarian reserve status was noted, along with improved intracytoplasmic sperm injection (ICSI) cycle performance concerning POR participants. Menstruation recovery was observed in 18 out of 30 POI patients, along with a statistically significant improvement on levels of AMH, FSH, and AFC. Similarly, 13 out of 30 menopausal women positively responded to PRP treatment. Finally, menstruation regularity, improved hormonal levels and AFC were reported for 24 out of 30 perimenopausal women. To conclude, PRP infusion appears to convey promising results in addressing ovarian insufficiency. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
50. Investigating Stress Response during Vaginal Delivery and Elective Cesarean Section through Assessment of Levels of Cortisol, Interleukin 6 (IL-6), Growth Hormone (GH) and Insulin-Like Growth Factor 1 (IGF-1).
- Author
-
Kiriakopoulos, Nikolaos, Grigoriadis, Sokratis, Maziotis, Evangelos, Philippou, Anastasios, Rapani, Anna, Giannelou, Polina, Tsioulou, Petroula, Sfakianoudis, Konstantinos, Kontogeorgi, Adamantia, Bakas, Panagiotis, Mastorakos, George, Koutsilieris, Michael, and Simopoulou, Mara
- Subjects
SOMATOMEDIN C ,CESAREAN section ,SOMATOTROPIN ,CORD blood ,HYDROCORTISONE - Abstract
Background: How do stress related phenomena during labor differ between vaginal delivery (VD) and elective cesarean section (CS), remains of heightened interest. The purpose of this study is to investigate discrepancies regarding the stress response during VD and CS. Methods: Cortisol, interleukin 6 (IL-6), growth hormone (GH) and insulin-like growth factor 1 (IGF-1) levels from parturients' peripheral blood were evaluated on three time-points, namely during the first stage of labor (TP1), two hours post labor (TP2) and 48 h post labor (TP3). Levels were also evaluated from the umbilical cord blood. A total of 50 women were enrolled in this prospective cohort study, with 24 and 26 subjected to CS and VD, respectively. Results: No statistically significant differences were observed between the two groups at TP1. Only GH levels presented the same pattern during the three time-points among both groups. In the umbilical cord blood, the CS group presented statistically significant higher IGF-1 and GH levels. In the umbilical cord blood, IGF-1 and GH levels were positively correlated, while GH and cortisol levels were negatively correlated. Conclusion: CS is a less stressful procedure than VD and is further associated with less intense inflammation, albeit with a longer inflammatory response period. Labor physiology during CS differs considerably regarding respective observations during VD. This merits extensive investigation in order to decipher these data for optimal clinical practice and guidelines. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.